Hi, Vmos
thanks for sharing, I Would love that to happen. However, in my opinion your number is a bit too optimistic. There are couple reasons for that, one is we plan to get FDA approval sometime in 2022 if I remember correctly? It could take time to get approval in other regions. Plus, when new tech come to the market I think it takes time for the market to adopt it. So I would not expect to sell too many devices in the first year after FDA approval.
In addition, it also takes time for the scaling of production. That's a lot of work for a medical devices company.
I believe the potential for EMV is enormous, but I just think it would require some time to get there. Happy to be wrong though
EMvision Research Notes, page-930
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.040(1.87%) |
Mkt cap ! $179.5M | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.15 | $2.10 | $72.21K | 34.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 227 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |